Fredrik Wärnberg
-
Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without
Radiotherapy
S. Weinmann, M. C. Leo, M. Francisco, C. L. Jenkins, T. Barry, G. Leesman, S. P. Linke, P. W. Whitworth, R. Patel, J. Pellicane, Fredrik Wärnberg, T. Bremer
Clinical cancer research : an official journal of the American Association for Cancer Research - 2020-01-01 -
LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic
target
C. Hagerling, M. Owyong, V. Sitarama, C. Y. Wang, C. Lin, R. J. E. van den Bijgaart, C. D. Koopman, A. Brenot, A. Nanjaraj, Fredrik Wärnberg, K. Jirstrom, O. D. Klein, Z. Werb, V. Plaks
Bmc Cancer - 2020-01-01 -
Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS
Trial.
Fredrik Wärnberg, Hans Garmo, Stefan Emdin, Veronica Hedberg, Linda Adwall, Kerstin Sandelin, Anita Ringberg, Per Karlsson, Lars-Gunnar Arnesson, Harald Anderson, Karin Jirström, Lars Holmberg
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 2014-01-01